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horses and 1 from Cx. tarsalis 
mosquitoes. Notably, our sequence 
is distantly related to GQ287646, 
which was  isolated from Culex spp. 
mosquitoes in Chaco, Argentina. The 
nucleotide sequence of the positive 
control VEEV-Tc83 is correctly placed 
in the VEEV clade.
Clinical and laboratory fi ndings 
showed that the illness described here 
was compatible with viral encephalitis. 
Using a generic RT-PCR assay on 
an early CSF sample, we amplifi ed 
a partial sequence (NSP4 gene) of 
an alphavirus. Phylogenetic analyses 
showed that the patient’s sequence 
grouped with sequences from WEEV, 
with high statistical support. A second 
RT-PCR assay on the NSP1 gene 
enabled us to obtain an amplifi cation 
of 208 bp, which is consistent with the 
expected size for WEEV. Therefore, 
we concluded that the fatal disease 
was likely caused by WEEV. Since the 
1970s, to our knowledge, the presence 
of WEEV (or other alphaviruses) in 
Uruguay has not been documented. 
Moreover, no recent reports have been 
made of genome detection of WEEV 
in encephalitis cases in the region. 
Although the case described here 
may be rare, the etiology of many viral 
encephalitides in Uruguay remains 
unknown. Serologic studies in horses 
and studies to detect arboviruses 
in mosquito populations are being 
conducted to investigate the status of 
arbovirus infections in Uruguay.
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Monotherapy in the 
United States 
To the Editor: Artemisinin-
based combination therapies are 
recommended as fi rst line treatments 
for Plasmodium falciparum malaria 
in most areas of the world. The 
article by Shahinas et al. (1) describes 
a patient who had P. falciparum 
malaria after returning from Nigeria. 
Her isolate had an elevated 50% 
inhibitory concentration to artemisinin 
derivatives. She had obtained 
artesunate in Nigeria and took it 
weekly for malaria prophylaxis, which 
might have contributed to the relative 
resistance found.
In 2009, one artemisinin-based 
combination therapy (artemether/
lumefantrine) became available for use 
in the United States. However, it is not 
widely appreciated that artemisinin is 
actually available in the United States 
as an herbal supplement for over-the- 
counter purchase (2). It is marketed 
for general health maintenance and 
for treatment of parasitic infections 
and cancers (Figure), although as with 
other supplements it is not intended to 
diagnose, treat, cure, or prevent any 
disease. As in the patient described 
by Shahinas et al., widespread use 
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of artemisinin or its derivatives as 
monotherapies could potentially lead 
to progressively increasing resistance 
in P. falciparum malaria (3). Studies in 
western Cambodia, where artemisinin 
monotherapy has been available for 
many years, have revealed in vivo 
artesunate resistance, with markedly 
decreased parasite clearance times 
(3). Progressive spread of artemisinin 
resistance could have disastrous 
consequences for the global control 
of malaria. Thus, minimally regulated 
use of potent compounds in dietary 
supplements has the potential for 
major public health implications.
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Yersinia pestis DNA 
Sequences in Late 
Medieval Skeletal 
Finds, Bavaria
To the Editor: We read with 
interest the report by Wiechmann et 
al. that, in the investigation of late 
medieval plague,  partial sequencing 
of the Yersinia pestis pPCP1 plasmid 
yielded the observation of a 3-T 
homopolymeric tract which differed 
from the 5-T homopolymeric tract 
of the Orientalis Y. pestis CO92 
type strain (1). This observation was 
unexpected because previous data 
from multispacer sequence typing 
and glp D gene sequencing yielded 
only the Orientalis biotype in cases of 
ancient plague (2). 
Using suicide PCR (3), we 
therefore further investigated pPCP1 
in 10 negative control dental pulp 
specimens and 60 specimens collected 
from 1 Justinian Orientalis plague site 
(2), 2 Black Death Orientalis sites, 
and 2 additional medieval plague 
sites. All negative controls remained 
negative; 14 (23%) of 60 plague 
specimens yielded a PCR product, 
and 7 interpretable sequences yielded 
a 3-T homopolymeric tract in all 
cases.
We further tested a Y. pestis 
isolate collection comprising 2 
Antiqua, 6 Medievalis, and 4 
Orientalis strains. No amplifi cation 
was obtained in DNA-free PCR mix 
and 5 Y. enterocolitica–negative 
control isolates, whereas sequencing 
yielded a 3-T homopolymeric tract in 
all 12 Y. pestis isolates.
BLAST analysis (http://blast.
ncbi.nlm.nih.gov/blast.cgi) indicated 
that the 5-T homopolymeric tract 
has been found only once in the Y. 
pestis CO92 strain (4) and in none of 
22 modern and 11 ancient sequences 
(Table). This 5-T homopolymeric 
tract is therefore CO92 strain 
specifi c and not a marker for the 
Orientalis biotype. This pPCP1 
plasmid sequence, located into a 
noncoding region of the 3′ extremity 
of the plasmid, is characterized by 
several homopolymeric tracts of 
poly (A) and poly (T), including the 
1 herein investigated. Instability of 
the T-stretches has been reported in 
bacterial genomes (5) as being hot 
spots for mutations (5).
Therefore, in our assessment, the 
data reported for the late medieval 
Bavaria burial (1) do not support that 
deaths of persons buried in this site 
resulted from a non-Orientalis plague. 
Typing modern or ancient Y. pestis 
strains should not rely on poly (A) 
and poly (T) homopolymeric tracts 
sequencing.
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Figure. Bottle of artemisinin, available over-
the-counter as an herbal supplement.
